Literature DB >> 25104172

Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.

Jian-Jun Yang1, Nan Wang1, Chun Yang2, Jin-Yun Shi3, Hai-Ying Yu4, Kenji Hashimoto5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25104172     DOI： 10.1016/j.biopsych.2014.06.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  59 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 2.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

Review 3.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

4.  Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.

Authors:  Sara Costi; Nicholas T Van Dam; James W Murrough
Journal:  Curr Behav Neurosci Rep       Date:  2015-10-01

5.  Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.

Authors:  Ebrahim Haroon; Alexander W Daguanno; Bobbi J Woolwine; David R Goldsmith; Wendy M Baer; Evanthia C Wommack; Jennifer C Felger; Andrew H Miller
Journal:  Psychoneuroendocrinology       Date:  2018-05-19       Impact factor: 4.905

6.  Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.

Authors:  Jennifer L Kruse; Joshua Hyong-Jin Cho; Richard Olmstead; Lin Hwang; Kym Faull; Naomi I Eisenberger; Michael R Irwin
Journal:  Psychoneuroendocrinology       Date:  2019-07-03       Impact factor: 4.905

Review 7.  Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.

Authors:  Steven J Pennybaker; Mark J Niciu; David A Luckenbaugh; Carlos A Zarate
Journal:  J Affect Disord       Date:  2016-10-26       Impact factor: 4.839

8.  NOX2 Mediated-Parvalbumin Interneuron Loss Might Contribute to Anxiety-Like and Enhanced Fear Learning Behavior in a Rat Model of Post-Traumatic Stress Disorder.

Authors:  Fang-Fang Liu; Lin-Dong Yang; Xiao-Ru Sun; Hui Zhang; Wei Pan; Xing-Ming Wang; Jian-Jun Yang; Mu-Huo Ji; Hong-Mei Yuan
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

9.  (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation.

Authors:  Jiancheng Zhang; Li Ma; Xiayun Wan; Jiajing Shan; Youge Qu; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2021-07-27       Impact factor: 4.530

10.  Infusing hope into the treatment of suicidality: A review of ketamine's effects on suicidality.

Authors:  Manivel Rengasamy; Kimberly Hsiung; Rebecca B Price
Journal:  Curr Behav Neurosci Rep       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.